The aim of this study was therefore to examine expression of survivin, survivin-2B and survivin-ΔEx3 mRNA in a large panel of primary breast carcinomas, axillary nodal metastases from primary breast cancers, fibroadenomas and normal breast tissues. The gene discussed is BIRC5; the disease is breast carcinoma.